KLK3 and prostate carcinoma: This work is consistent with prior studies examining downstream implications of low-value PSA testing in older adults.19,20,21 For example, Zanwar et al21 compared downstream tests, treatments, and payments for prostate cancer care in older Texas Medicare beneficiaries cared for by primary care practitioners (PCPs) with high or low PSA screening rates.